Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis

European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention

(2020) Alexander J. Stratigos et al.   EUROPEAN JOURNAL OF CANCER

Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial

(2020) Michael R Migden et al.   LANCET ONCOLOGY

Phase II Study of Pembrolizumab As First-Line, Single-Drug Therapy for Patients With Unresectable Cutaneous Squamous Cell Carcinomas

(2020) Eve Maubec et al.   JOURNAL OF CLINICAL ONCOLOGY

Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629)

(2020) Jean-Jacques Grob et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical outcomes among unresectable, locally advanced, and metastatic cutaneous squamous cell carcinoma patients treated with systemic therapy

(2020) C. Lance Cowey et al.   Cancer Medicine

Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing

(2020) Danny Rischin et al.   Journal for ImmunoTherapy of Cancer

Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials

(2019) Yucai Wang et al.   JAMA Oncology

Cutaneous squamous cell carcinoma

(2018) Syril Keena T. Que et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

(2018) Michael R. Migden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Characterization of the Anti–PD-1 Antibody REGN2810 and Its Antitumor Activity in Human PD-1 Knock-In Mice

(2017) Elena Burova et al.   MOLECULAR CANCER THERAPEUTICS

Orbital exenteration for advanced periorbital non-melanoma skin cancer: prognostic factors and survival

(2016) R C Gerring et al.   EYE

Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline

(2015) Alexander Stratigos et al.   EUROPEAN JOURNAL OF CANCER

Vision-Related Quality of Life and Appearance Concerns Are Associated with Anxiety and Depression after Eye Enucleation: A Cross-Sectional Study

(2015) Juan Ye et al.   PLoS One

Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital Tumor Staging for Cutaneous Squamous Cell Carcinoma

(2013) Pritesh S. Karia et al.   JOURNAL OF CLINICAL ONCOLOGY

Health-Related Quality of Life After Surgical Removal of an Eye

(2013) Takaaki Kondo et al.   OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY

Factors Predictive of Recurrence and Death From Cutaneous Squamous Cell Carcinoma

(2013) Chrysalyne D. Schmults et al.   JAMA Dermatology

Itch and Pain in Nonmelanoma Skin Cancer: Pain as an Important Feature of Cutaneous Squamous Cell Carcinoma

(2012) Kyle C. Mills et al.   ARCHIVES OF DERMATOLOGY

Treatment of Unresectable and Metastatic Cutaneous Squamous Cell Carcinoma

(2010) L. D. Cranmer et al.   ONCOLOGIST